COMMUNIQUÉS West-GlobeNewswire

Tecan to host Analyst and Media Conference with Capital Markets Update on March 16, 2026
10/02/2026
Männedorf, Switzerland, February 10, 2026 – The Tecan Group (SIX Swiss Exchange: TECN) will hold an Analyst and Media Conference on Monday, March 16, 2026, at 2:00 pm CET to present its full-year 2025 financial results [...]
MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System
10/02/2026
CLEARWATER, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- via IBN – MedWell Ai, Inc ("Company") (OTCQB: MWAI) is pleased to announce the signing of a Letter of Intent (“LOI”) to create a vertically integrated health, wellness [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
10/02/2026
Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
IBA – ACQUISITION OF OWN SHARES
10/02/2026
Louvain-la-Neuve, Belgium, February 10 th , 2026 – 6 PM CET – In accordance with article 8:4 of the Royal Decree of 29 April 2019 executing the Belgian Code on Companies and Associations, Ion Beam Applications SA (“IBA [...]
BioCardia Files Pre-Submission for FDA Approval of Helix™ Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart
10/02/2026
SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported it [...]
Hassan Spine & Sports Medicine Rebrands as NefraHealth
10/02/2026
New Identity Reflects Patient-First Philosophy, Practice Growth Board-Certified Spine Surgeon Joins Growing Central Jersey Practice OLD BRIDGE, N.J., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hassan Spine & Sports Medicine [...]
BioAro Secures UAE Approval for AI-Enabled Longevity Bioactives, Setting the Stage for Global Expansion
10/02/2026
DUBAI, United Arab Emirates and TORONTO, Feb. 10, 2026 (GLOBE NEWSWIRE) -- BioAro Inc. , a biotechnology company at the forefront of precision health and longevity, has achieved a major milestone with regulatory [...]
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
10/02/2026
ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Exousia Pro, Inc. (OTCID: MAJI) , a clinical-stage biotechnology company specializing in proprietary exosome-based delivery systems, is pleased to announce a significant [...]
EssilorLuxottica: Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026
10/02/2026
Nombre total de droits de vote et d’actions composant le capital social au 31 janvier 2026 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Paris, [...]
IBA – ACQUISITION D’ACTIONS PROPRES
10/02/2026
Louvain-la-Neuve, Belgique, 10 février 2026 – 18h00 – Conformément à l'article 8:4 de l'arrêté royal du 29 avril 2019 portant exécution du Code belge des sociétés et associations, Ion Beam Applications SA ("IBA") [...]
Communiqué de presse : Sanofi finalise l’acquisition de Dynavax
10/02/2026
Sanofi finalise l’acquisition de Dynavax Paris, le 10 février 2026. Sanofi a annoncé aujourd’hui avoir finalisé l’ acquisition de Dynavax Technologies Corporation (Dynavax). L’acquisition comprend le vaccin contre l’ [...]
Hyagen Medical Launches National FDA Compliance and Education Initiative to Strengthen Regenerative Medicine Standards
10/02/2026
FDA-aligned education and compliance for ethical stem cell and regenerative medicine practices Lehi, UT, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Hyagen Medical , a regulatory compliance and education company specializing in [...]
Press Release: Sanofi completes the acquisition of Dynavax
10/02/2026
Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition includes Dynavax’s adult [...]
Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline
10/02/2026
WHO recognition of “etaroleucel” (CELZ-101) builds on prior “olastrocel” (CELZ-201) milestone, reinforcing platform credibility and supporting multi-program execution PHOENIX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Creative [...]
Codexis Achieves ISO 9001:2015 Certification
10/02/2026
REDWOOD CITY, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Codexis Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced today that it has earned [...]
Imprivata Introduces Advanced Access Management and Passwordless Authentication Capabilities to Improve User Efficiency and Strengthen Security
10/02/2026
Tailored for all users and workflows, Imprivata Enterprise Access Management now offers context-aware passwordless authentication, advanced biometrics, and AI-powered behavioral analytics to further streamline access to [...]
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
10/02/2026
The new partnership combines Weight Watchers’ scientifically-backed medical and behavioral expertise with PVOLVE’s clinically-studied method to support members at every age and stage of life NEW YORK, Feb. 10, 2026 ( [...]
PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExplore™ for Standardized Histopathology Endpoints
10/02/2026
BOSTON, Feb. 10, 2026 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, today announced the strategic expansion of its support of inflammatory bowel disease clinical trials on the AISight® Clinical [...]
Polaryx Announces Key Pre-Clinical Data Related to SOTERIA at the 22nd Annual WORLDSymposium™
10/02/2026
Oral presentation highlighted the effect of gemfibrozil on Krabbe disease, one of four LSDs in the upcoming Phase 2 SOTERIA basket trial evaluating PLX-200 (reformulated gemfibrozil) PARAMUS, NJ, Feb. 10, 2026 (GLOBE [...]

Pages